Harmony Biosciences Holdings annual revenue
2019
2020
2021
2022
2023
2024
2025
Harmony Biosciences Holdings Revenue Growth & History (HRMY)
Harmony Biosciences Holdings reported $868.5M in revenue for fiscal 2025, an increase of 21.51% from the previous fiscal year.
View full Harmony Biosciences Holdings company overviewHarmony Biosciences Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $868.5M | $153.7M | +21.51% |
| 2024 | 2024-12-31 | $714.7M | $132.7M | +22.80% |
| 2023 | 2023-12-31 | $582.0M | $144.2M | +32.93% |
| 2022 | 2022-12-31 | $437.9M | $132.4M | +43.35% |
| 2021 | 2021-12-31 | $305.4M | $145.7M | +91.21% |
| 2020 | 2020-12-31 | $159.7M | $153.7M | +2564.59% |
| 2019 | 2019-12-31 | $6.0M | — | — |
Harmony Biosciences Holdings quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $261.3M | $60.8M | +30.32% |
| Q1 2026 | 2026-03-31 | $215.4M | $30.7M | +16.59% |
| Q4 2025 | 2025-12-31 | $243.8M | $42.5M | +21.12% |
| Q3 2025 | 2025-09-30 | $239.5M | $53.4M | +28.71% |
| Q2 2025 | 2025-06-30 | $200.5M | $27.7M | +16.01% |
| Q1 2025 | 2025-03-31 | $184.7M | $30.1M | +19.48% |
| Q4 2024 | 2024-12-31 | $201.3M | $32.9M | +19.51% |
| Q3 2024 | 2024-09-30 | $186.0M | $25.8M | +16.08% |
| Q2 2024 | 2024-06-30 | $172.8M | $38.6M | +28.76% |
| Q1 2024 | 2024-03-31 | $154.6M | $35.5M | +29.79% |
| Q4 2023 | 2023-12-31 | $168.4M | $40.1M | +31.26% |
| Q3 2023 | 2023-09-30 | $160.3M | $43.1M | +36.74% |
| Q2 2023 | 2023-06-30 | $134.2M | $27.2M | +25.40% |
| Q1 2023 | 2023-03-31 | $119.1M | $33.8M | +39.63% |
| Q4 2022 | 2022-12-31 | $128.3M | $37.1M | +40.67% |
| Q3 2022 | 2022-09-30 | $117.2M | $36.5M | +45.18% |
| Q2 2022 | 2022-06-30 | $107.0M | $33.2M | +44.98% |
| Q1 2022 | 2022-03-31 | $85.3M | $25.6M | +42.97% |
| Q4 2021 | 2021-12-31 | $91.2M | $34.9M | +62.05% |
| Q3 2021 | 2021-09-30 | $80.7M | $35.1M | +77.01% |
| Q2 2021 | 2021-06-30 | $73.8M | $35.8M | +94.24% |
| Q1 2021 | 2021-03-31 | $59.7M | $39.8M | +200.78% |
| Q4 2020 | 2020-12-31 | $56.3M | — | — |
| Q3 2020 | 2020-09-30 | $45.6M | — | — |
| Q2 2020 | 2020-06-30 | $38.0M | — | — |
| Q1 2020 | 2020-03-31 | $19.8M | — | — |
Harmony Biosciences Holdings revenue growth trends
Over the last five reported fiscal years, revenue grew from $159.7M to $868.5M, a compound annual growth rate of 40.30%. Harmony Biosciences Holdings's latest reported quarter, Q2 2026, generated $261.3M in revenue, an increase of 30.32% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Harmony Biosciences Holdings source filings ↗